(Q48444944)

11 February 2018

title

Intermittent hypoxia: the culprit of oxidative stress, vascular inflammation and dyslipidemia in obstructive sleep apnea (English)

1 reference

11 February 2018

0 references

1 reference

Lena Lavie

1

1 reference

11 February 2018

publication date

1 February 2008

1 reference

11 February 2018

Expert Review of Respiratory Medicine

published in

1 reference

11 February 2018

volume

2

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

75-84

1 reference

11 February 2018

The pathogenesis of atherosclerosis--an update

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Cardiovascular consequences of obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

21 January 2018

Obstructive sleep apnoea

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Abnormal lipid peroxidation in patients with sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Obstructive sleep apnoea syndrome--an oxidative stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

The occurrence of sleep-disordered breathing among middle-aged adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

An independent association between obstructive sleep apnoea and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Association of hypertension and sleep-disordered breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Prospective study of the association between sleep-disordered breathing and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Obstructive sleep apnea as a risk factor for stroke and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

HDL dysfunction in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Phagocytes and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Oxidative stress in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Association between lipid peroxidation and inflammation in obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Oxidants as stimulators of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Intermittent hypoxia induces hyperlipidemia in lean mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Erythropoietin and obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

GATA transcription factors in the developing and adult heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Acute intermittent hypoxia activates myocardial cell survival signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Evidence for activation of nuclear factor kappaB in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Activated CD8+ T-lymphocytes in obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Phenotypic and Functional Characterization of Blood γδ T Cells in Sleep Apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Hematocrit levels in sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Good soldier falls: the liver in sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Chronic intermittent hypoxia induces atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Plasma Levels of Nitric Oxide and L-Arginine in Sleep Apnea Patients: Effects of nCPAP Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Early signs of atherosclerosis in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

The prevalence of calcified carotid artery atheromas in patients with obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Pulse wave velocity as an indicator of atherosclerosis in obstructive sleep apnea syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

Oxygen-derived free radicals in postischemic tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.1.75

21 January 2018

Identifiers

DOI

10.1586/17476348.2.1.75

1 reference

11 February 2018

1 reference

11 February 2018